vimarsana.com
Home
Live Updates
Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix™ Product Platform : vimarsana.com
Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix™ Product Platform : vimarsana.com
Orthox Announces MHRA Authorisation for Clinical Trial of Knee Cartilage Repair FibroFix™ Product Platform
/PRNewswire/ -- Orthox Limited, a clinical stage company developing medical implants to repair damaged knee articular cartilage and other orthopaedic injuries,...
Related Keywords
Germany ,
Australia ,
Bristol ,
City Of ,
United Kingdom ,
Budapest ,
Hungary ,
China ,
Oxfordshire ,
France ,
Australian ,
Hungarian ,
Nick Skaer ,
Orthox Fibrofix ,
Michael Whitehouse ,
International Orthopaedics ,
Biomedical Catalyst Fund Award ,
Scius Communications ,
Bristol Biomedical Research Centre ,
Department Of Health ,
Wellcome ,
Stage Product Development ,
University Of Bristol ,
Oxford University ,
European Innovation Council ,
United Kingdom Innovation Agency ,
Orthox Ltd ,
National Institute For Health ,
Care Research ,
Agency For Healthcare Research ,
Orthox Limited ,
National Institute ,
Wellcome Trust ,
Southmead Hospital ,
North Bristol ,
Study Chief Investigator ,
Biomedical Research Centre ,
Healthcare Research ,
Translation Awards ,
Late Stage Product Development Awards ,
Innovation Agency ,
United Kingdom Aid ,
Biomedical Research ,
Orthox ,